Recent 8-K filings for STSS
Highest-materiality recent filing
Sharps Technology closes $410M private placement, launches Solana treasury; could raise up to $1B
- Gross proceeds ~$410.9M from ~24.3M shares at $6.50 plus pre-funded/stapled warrants; additional $600M possible if all warrants exercised.
- Launched Solana digital asset treasury strategy; current position over 2 million SOL; plans to acquire more in open market.
-
Sharps Tech appoints Arthur Levine as interim CFO at $450/hr effective Feb 17, 2026
Arthur Levine appointed interim CFO via fee agreement with DLA, LLC; initial term 3 months, extendable.
-
Sharps Technology adopts amended bylaws, code of ethics, and board committee charters
Amended bylaws add advance notice for stockholder proposals and director nominations, plus Nevada exclusive forum.
-
Sharps Technology enters 90-day lock-up with advisor SOL Markets; announces $100M buyback
SOL Markets voluntarily restricts sales of advisory warrants and underlying shares for 90 days, effective Jan 16, 2026.
-
Annemarie Tierney resigned as Independent Director and from Audit and Compensation Committees, effective Dec 19, 2025.
-
Special meeting quorum of 66.9% achieved (17,779,090 of 26,600,848 shares present); all four proposals passed.
-
Sharps Technology authorizes $100M share repurchase program with Cantor Fitzgerald agent
Board approved up to $100M repurchase of common stock on October 2, 2025.
-
Sharps Technology authorizes $100M stock repurchase program, acquires 2M+ SOL tokens
Board authorized up to $100M stock repurchase of common shares in open market and negotiated transactions.
-
Sharps Technology settles litigation, transfers Safegard Medical Kft assets
Signed confidential settlement on Oct 6, 2025 with Barry Berler, Plastomold and affiliates, resolving all litigation claims.
-
Sharps Technology extends registration statement filing deadline via waiver
Waiver and Consent signed with holders of over 50.1% of registrable securities, extending initial resale registration filing deadline.
-
Sharps Technology closes $410M private placement, launches Solana treasury; could raise up to $1B
Gross proceeds ~$410.9M from ~24.3M shares at $6.50 plus pre-funded/stapled warrants; additional $600M possible if all warrants exercised.
-
Sharps Technology enters $236.6M ATM equity offering with Cantor and Aegis
Up to $236,605,575 in common stock may be sold from time to time under the Sales Agreement.
-
Sharps Technology launches $400M crypto treasury offering, CEO resigns, shares increased
Raised ~$400M gross in a private placement of shares and warrants, both for cash and cryptocurrency (USDC/USDT or SOL tokens).
-
Issued 5 shares of Series B Preferred Stock to Executive Chairman Paul Danner for $100 total ($20/share) on July 17, 2025.
-
Sharps Technology appoints Paul Danner as Executive Chairman; committee reshuffle
Paul Danner appointed Executive Chairman on June 30, 2025, replacing non-executive Chairman Soren Christiansen.
-
Sharps begins first commercial shipments; transitions to revenue-generating stage
Initiated shipments under three customer orders; first commercial revenue from $500K total purchase commitments.
-
Sharps Technology regains Nasdaq minimum bid price and equity compliance
Received Nasdaq notice confirming compliance with $1.00 minimum bid price and $2.5M equity requirements.
-
Sharps Technology reports 1,019,078 shares outstanding after reverse split
1,019,078 shares of common stock outstanding as of May 7, 2025.
-
Purchase order of $100K from a Hungarian vaccine provider for SecureGard retractable syringes; first SecureGard order from this customer.
-
Sharps Technology receives $400K initial purchase order under $50M supply agreement
Initial $400K purchase order from U.S. leader in IV flushing solutions under July 2024 $50M, 5-year supply agreement.
-
Sharps Technology: 1-for-300 reverse stock split effective April 27, 2025
Reverse stock split 1:300 approved, effective at 11:59 p.m. ET on April 27, 2025.
-
Sharps Technology announces 1-for-300 reverse stock split effective April 27, 2025
Reverse split ratio 1-for-300, effective April 27, 2025 at 11:59 PM ET; post-split trading starts April 28.
-
Sharps receives Nasdaq notice for late Clawback adoption; matter now closed
Failed to adopt Clawback Policy under Nasdaq Rule 5608(b)(1) until April 15, 2025.
-
Sharps Technology reports 97% of 2025 Series B Warrants exercised as of April 14
286,621,057 Class B cashless Warrants exercised, representing 97% of the 2025 Series B Warrants.
-
Sharps Technology receives Nasdaq deficiency notice for stockholders' equity below $2.5M requirement
Stockholders' equity of $1,996,129 as of Dec 31, 2024, below $2.5M minimum for continued listing.
-
Sharps Technology reports 199.8M Class B Warrants exercised as of April 2, 2025
199,765,734 Class B Warrants exercised in connection with January 29, 2025 public offering.
-
Sharps Technology shareholders reject reverse stock split; warrant issuance approved
Proposal for reverse stock split (1:3 to 1:11) failed: 3,442,858 for, 879,909 against; did not meet majority of outstanding shares.
-
Stockholders approve warrant issuance; exercise floor price set at $0.292
Special meeting held March 28, 2025; stockholders authorized issuance of warrants and underlying shares.
-
Special shareholder meeting scheduled for March 28, 2025, to vote on reverse stock split proposal.
-
Sharps Tech gets Nasdaq delisting notice for bid price non-compliance; will appeal
Notified on March 12, 2025 for failing to maintain minimum $1.00 bid price for 30 consecutive days.
Materiality & sentiment trend
Max materiality 0.95 · Median 0.65 · Most common event other_material